Table 1.
Gene | Primer | Sequence | Accession number | Tm (°C) | Product size (bp) |
---|---|---|---|---|---|
BDNF | Forward | 5′-TGG CTG ACA CTT TTG AGC AC-3′ | NM_001048142 | 55 | 188 |
Reverse | 5′-GTT TGC GGC ATC CAG GTA AT-3′ | ||||
Exon I | Forward | 5′-TGA GAG TTG AAG CTT TGC GG-3′ | EF125669.1 | 55 | 189 |
Reverse | 5′-ATT GTG GCT TTG CTG TCC TG-3′ | ||||
Exon IIC | Forward | 5′-TTT GGT CCC CTC ATT GAG CT-3′ | EF125672.1 | 55 | 159 |
Reverse | 5′-TTC TTT GCG GCT TAC ACC AC-3′ | ||||
Exon III | Forward | 5′-TCT ATC ATC CCT CCC CGA GA-3′ | EF125681.1 | 55 | 123 |
Reverse | 5′-AAC TGG GCT CAA GGA AGC AT-3′ | ||||
Exon IV | Forward | 5′-AGC ATG AAA TCT CCC AGC CT-3′ | EF125673.1 | 55 | 213 |
Reverse | 5′-CGG TCC CCA AGG TTC TAG AC-3′ | ||||
Exon V | Forward | 5′-TAG CTT TGT GGT GCG GGA AG-3′ | EF125682.1 | 57 | 146 |
Reverse | 5′-AAG TTG CCT TGT CCG TGG A-3′ | ||||
Exon VI | Forward | 5′-GGG CTT GGA GAA GGA AAC CG-3′ | EF125674.1 | 55 | 188 |
Reverse | 5′-GGT CCA CAC AAA GCT CTC GG-3′ | ||||
Exon VII | Forward | 5′-CTG TCA CCT GCT CTC TAG GG-3′ | EF125683.1 | 55 | 118 |
Reverse | 5′-AGT TCC GCA GAC CCT TTC AG-3′ | ||||
Exon VIII | Forward | 5′-CAA CTG GAT GTG TGG AAC CA-3′ | EF125684.1 | 55 | 128 |
Reverse | 5′-AGT GTG TGG GTA GAT GCC AA-3′ | ||||
Exon IXA | Forward | 5′-ATT TGT GTC CCC TGC AGC T-3′ | EF125685.1 | 55 | 151 |
Reverse | 5′-GTG GGA AGG AAG CAG AGA CA-3′ | ||||
GAPDH | Forward | 5′-TCC ATG ACA ACT TTG GCA TT-3′ | NM_008084.2 | 55 | 377 |
Reverse | 5′-GTT GCT GTT GAA GTC GCA GG-3′ |
BDNF, brain-derived neurotrophic factor; GAPDH, glyceraldehyde three-phosphate dehydrogenase.